Access
This article is part of Nature's premium content.
Published online 10 October 2007 | Nature | doi:10.1038/449651a
Patent crunch pending
Drug makers are fighting a rear-guard action against patent laws that are before the US Congress. Meredith Wadman reports.
To read this story in full you will need to login or make a payment (see right).
Comments
Reader comments are usually moderated after posting. If you find something offensive or inappropriate, you can speed this process by clicking 'Report this comment' (or, if that doesn't work for you, email redesign@nature.com). For more controversial topics, we reserve the right to moderate before comments are published.